Loading [Contrib]/a11y/accessibility-menu.js
Skip to main content
null
J Orthopaedic Experience & Innovation
  • Menu
  • Articles
    • Brief Report
    • Case Report
    • Data Paper
    • Editorial
    • Hand
    • Meeting Reports/Abstracts
    • Methods Article
    • Product Review
    • Research Article
    • Review Article
    • Review Articles
    • Systematic Review
    • All
  • For Authors
  • Editorial Board
  • About
  • Issues
  • Blog
  • "Open Mic" Topic Sessions
  • Advertisers
  • Recorded Content
  • CME
  • JOEI KOL Connect
  • search

RSS Feed

Enter the URL below into your favorite RSS reader.

https://journaloei.scholasticahq.com/feed
Research Article
Vol. 3, Issue 1, 2022March 06, 2022 EDT

Location of Disc Herniation May Affect Outcomes Following Lumbar Decompression

Kevin C. Jacob, BS, Madhav R. Patel, BS, Elliot D.K. Cha, MS, Conor P. Lynch, MS, Shivam Patel, Andrew P. Collins, BS, Hanna Pawlowski, BS, Michael C. Prabhu, BS, Nisheka N. Vanjani, BS, Kern Singh, MD,
minimally invasive lumbar decompressiondisc herniationpatient reported outcome measures
Copyright Logoccby-nc-nd-4.0
J Orthopaedic Experience & Innovation
Jacob, Kevin C., Madhav R. Patel, Elliot D.K. Cha, Conor P. Lynch, Shivam Patel, Andrew P. Collins, Hanna Pawlowski, Michael C. Prabhu, Nisheka N. Vanjani, and Kern Singh. 2022. “Location of Disc Herniation May Affect Outcomes Following Lumbar Decompression.” Journal of Orthopaedic Experience & Innovation 3 (1).
Save article as...▾

View more stats

Abstract

Objective

While prior literature have compared postoperative outcomes between surgical and non surgical options based on lumbar disc herniation location and size, postoperative outcome evaluation of decompressive surgical interventions by disc herniation location and size are sparse. The objective of the study was to evaluate the impact of different Lumbar disc herniations (LDH) on patient reported outcomes (PROMs) following minimally invasive lumbar decompression (MIS LD).

Methods

MIS LD procedures were identified from a surgical database. PROMs, including Visual Analog Scale (VAS) back/VAS leg/Oswestry Disability Index (ODI)/ Short Form Physical Component Score (SF-12 PCS)/ Patient-Reported Outcome Measurement Information System- physical Function (PROMIS- PF)/ Patient Health Questionnaire-9 (PHQ-9), were collected preoperatively and postoperatively. Minimum clinically important difference (MCID) achievement was calculated. Patients were grouped by herniation location and size as follows: paracentral/central with a massive, extruded lumbar disc (HNP I); extraforaminal/far lateral lumbar disc herniation (HNP II). Improvements in PROMs were evaluated using a paired Student’s t-test. Differences in mean scores and variations in MCID achievement rates between groups at each timepoint were evaluated using a simple logistic regression.

Results

The study cohort included 142 patients. Groups differed in age, insurance collected, and hypertension. HNP I patients demonstrated significant improvements in ODI, SF-12 PCS, PROMIS PF, and PHQ-9 through the 2-year timepoint. HNP II patients demonstrated significant improvements through 12-weeks for SF-12 PCS and PROMIS PF, and through 6-months for ODI, and only at the 6-month timepoint for PHQ-9 . Location and size of herniations demonstrated a significant effect on outcomes for VAS leg, ODI, SF-12 PCS, PROMIS PF, and PHQ-9 at intermittent timepoints, all). LDHs properties did not impact MCID achievement rates .

Conclusion

Depending on the size and location of a herniation, patients may experience varying degrees of improvement throughout their course of postoperative recovery but will ultimately arrive at a similar resolution of symptoms.

Introduction

Lumbar disc herniation (LDH) is a common source of radiculopathy, characterized by radiating pain to the lower extremities, in the presence of absence of back pain. In severe cases, the compressed nerve roots may cause impaired sensory and motor function to the innervated areas (Amin, Andrade, and Neuman 2017; Allen et al. 2009). Different locations of LDHs can vary in their presentation and possible resolution of symptoms, dependent on the nerve roots impinged and characteristics of the herniated nucleus pulposus (Amin, Andrade, and Neuman 2017). While the natural disease history for LDH is generally favorable, surgery may be an option for patients who fail conservative management and have persistent neurological dysfunction or severe pain. Minimally invasive lumbar decompression (MIS LD) has become a staple for surgical intervention of single and multilevel LDH as the procedure has demonstrated effective results in relieving symptoms of disc herniation (Khanna et al. 2021; Weinstein et al. 2006, 2008). MIS LD was developed with the intent of diminishing risk of postoperative instability by preserving spinal musculature and requiring minimal posterior element disruption. This goal is achieved via tubular-access approaches developed to allow for unilateral or bilateral lumbar decompression via a combination of laminectomy, facetectomy, and foraminotomy (Narain et al. 2017). To assess successful outcomes following spinal surgery, increasing focus has been placed on Patient Reported Outcome Measures (PROMs), which provide insight to the patient’s perception of their own health status (Jenkins et al. 2020; Patel et al. 2019; Finkelstein and Schwartz 2019; McCormick, Werner, and Shimer 2013). In lumbar spine surgery, common PROMs utilized include the Visual Analog Scale (VAS) for back and leg pain, Oswestry Disability Index (ODI), 12-Item Short-Form (SF-12) Physical Component Summary (PCS), Patient Reported Outcome Measurement Information System Physical Function (PROMIS-PF), and Patient Health Questionnaire-9 (PHQ-9) (Jenkins et al. 2020; Patel et al. 2019; Finkelstein and Schwartz 2019; McCormick, Werner, and Shimer 2013). While PROMs can evaluate statistically significant change in quality of life measures this does not necessarily indicate meaningful postoperative clinical improvement. To address this shortcoming, prior studies have evaluated threshold postoperative improvement values for each PROM denoting these calculated values as a Minimum Clinical Important Difference (MCID) (Parker et al. 2012; Hung et al. 2018). Given the frequency of LD surgery for the treatment of LDH and the variable demographic affected by the pathology, there has been increasing interest in factors that may influence perioperative PROMs in this population.

Previous studies have assessed the influence of sex on clinical outcomes following MIS LD (Nolte et al. 2021), noting similar PROMs and MCID achievement between males and females. Additionally, Goh et al. reported that preoperative mental health status may not affect postoperative satisfaction following spine surgery (Goh et al. 2021). However, studies comparing the impact of disc herniation location and size on PROMs following MIS LD have not been well described in the literature. While trials have assessed the necessity for surgical and nonsurgical treatment outcomes by LDH location and size (Kim et al. 2021; Gupta et al. 2020), postoperative outcome evaluation of decompressive surgical interventions are sparse.

Continued research is necessary to determine the clinical impact of LDH location on perioperative outcomes following MIS LD. By analyzing PROMs and MCID in these outcomes, greater clinical context may be determined to assess surgical success. These findings can benefit patient counseling on expectations and likely postoperative outcomes, while providing realistic data to inform patients on surgical options. Thus, the present study aims to elucidate the relationship between LDH location and the most commonly used PROMs and their MCID following MIS LD.

Methods

Patient Population

The Institutional Review Board (ORA #14051301) approved all aspects of the current study and all participants provided written informed consent prior to commencement. Eligible study participants were identified via a retrospective review of a single surgeon prospective database for spinal procedures performed at a single academic medical institution. Inclusion criteria for the study consisted of patients who underwent primary, elective, single-level MIS LD procedures. Any patient who had received a multi-level LD procedure or had been operated on for infection, malignancy, or trauma was excluded from the study.

Surgical Technique

Fluoroscopic imaging was used to localize the affected spinal level. A unilateral approach was undertaken via paramedian 2.0-cm skin incision. Sharp dissection was conducted to the level of the deep fascia where subsequently a series of tubular dilators were docked on to the interspace(s) of interest. The final working portal was either a 16- or 21-mm non-expandable tube. A high-speed drill performed a laminectomy with bilateral partial facetectomy and foraminotomy. The underlying ligamentum flavum was resected utilizing a 3-mm Kerrison rongeur. The exiting and traversing nerve roots were visualized and noted to have an excursion distance greater than 1 cm. In subset of patients requiring a concomitant discectomy, the traversing nerve root was medially mobilized and the underlying disk fragment was resected (Ahn et al. 2016).

Data Collection

Patients were separated into two cohorts, dependent on location of disc herniation. The HNP I cohort included paracentral/central herniation with a massive, extruded lumbar disc; the HNP II cohort consisted of extraforaminal/far lateral lumbar disc herniation. Demographic and perioperative characteristics were collected, including age, self-identified gender, body mass index (BMI), ethnicity, active smoker status, medical comorbidities (diabetic status, history of myocardial infarction, hypertension, arthritis, peripheral vascular disease, renal failure, and chronic lung disease), and insurance status. Burden of comorbidities and appropriateness for surgery were collected and evaluated with the Charlson Comorbidity Index and American Society of Anesthesiologists physical classification, respectively (Table 1). Perioperative characteristics were collected in this retrospective review. These variables included operative level, duration of preoperative symptoms, mean operative time, average intraoperative blood loss, total hospital or surgery center length of stay (LOS) in hours, and postoperative complications (Table 2).

Table 1.Baseline Characteristics
Characteristics Total (n=122) HNP I (n=74) HNP II (n=48) *p-value
Age (mean ± SD, years) 44.1 ± 12.5 40.8 ± 12.3 49.2 ± 11.0 <0.001
Body Mass Index (mean ± SD, kg/m2) 29.4 ± 5.9 28.9 ± 6.3 30.1 ± 5.2 0.251
Gender 0.502
Female 27.9% (34) 25.7% (19) 31.3% (15)
Male 72.1% (88) 74.3% (55) 68.7% (33)
Ethnicity 0.662
African American 9.8% (12) 9.5% (7) 10.4% (5)
Caucasian 72.1% (88) 74.3% (55) 68.7% (33)
Hispanic 14.8% (18) 12.2% (9) 18.7% (9)
Asian/Other 3.3% (4) 4.0% (3) 2.2% (1)
Diabetic Status 0.845
Non-Diabetic 94.3% (115) 94.6% (70) 93.7% (45)
Diabetic 5.7% (7) 5.4% (4) 6.3% (3)
Smoking Status 0.061
Non-Smoker 89.3% (109) 85.1% (63) 95.8% (46)
Smoker 10.7% (13) 14.9% (11) 4.2% (2)
ASA score 0.784
≤2 93.0% (93) 93.5% (58) 92.1% (35)
>2 7.0% (7) 6.5% (4) 7.9% (3)
CCI Score (mean ± SD) 0.92 ± 1.2 0.8 ± 1.1 1.1 ± 1.3 0.187
Insurance 0.040
Medicare/Medicaid 2.5% (3) 0.0% (0) 6.3% (3)
Workers’ Compensation 32.0% (39) 28.4% (21) 37.5% (18)
Private 65.5% (80) 71.6% (53) 56.2% (27)
Medical Comorbidities
Myocardial Infarction 1.6% (2) 2.7% (2) 0.0% (0) 0.251
Hypertension 19.7% (24) 12.2% (9) 31.3% (15) 0.010
Arthritis 5.7% (7) 5.4% (4) 6.3% (3) 0.874
Peripheral Vascular Disease 0.8% (1) 1.4% (1) 0.0% (0) 0.419
Renal Failure 0.8% (1) 1.3% (1) 0.0% (0) 0.419
Chronic Lung Disease 1.7% (2) 2.8% (2) 0.0% (0) 0.244

ASA = American Society of Anesthesiologists; CCI = Charlson Comorbidity Index; SD = standard deviation
Boldface indicates significance

Table 2.Perioperative Characteristics
Characteristics Total (n=122) HNP I (n=74) HNP II (n=48) *p-value
Operative Level
L2-3 4.1% (5) 5.4% (4) 2.1% (1)
L3-4 16.4% (20) 6.8% (5) 31.3% (15)
L4-5 45.1% (55) 41.9% (31) 50.0% (24)
L5-S1 34.4% (42) 45.9% (34) 16.7% (8)
Duration of Symptoms (Mean ± SD; days) 201.4 ± 201.3 166.7 ± 179. 253.9 ± 223.6 0.046
Operative Time (Mean ± SD; min) 46.7 ± 17.6 48.5 ± 19.9 43.7 ± 12.8 0.143
Estimated Blood Loss (Mean ± SD; mL) 28.5 ± 10.7 28.5 ± 11.5 28.4 ± 9.5 0.946
Length of Stay (Mean ± SD; hours) 7.5 ± 11.1 6.4 ± 7.9 9.4 ± 14.7 0.153
Postoperative Complications
*Urinary Retention 0.8% (1) 1.3% (1) 0.0% (0) 0.419

SD = standard deviation
* Patient had a post-void residual volume of 830cc on POD0 and underwent straight catheterization. Was able to spontaneously void by discharge on POD1

PROMs were utilized to assess postoperative outcomes in the cohorts. The PROMs evaluated in this analysis included the Visual Analog Scale back and leg (VAS back/leg), Oswestry Disability Index (ODI), Short Form 12-Item Physical Composite Score (SF-12 PCS), Patient-Reported Outcomes Measurement Information System-Physical Function (PROMIS-PF), and Patient Health Questionnaire (PHQ-9). All outcome measures were collected preoperatively as a baseline score, and at postoperative time points of 6-weeks, 12-weeks, 6-months, 1-year, and 2-year following surgery (Table 3). MCID was assessed for the study cohorts among PROMs to evaluate the impact of disc herniation location on rates of clinically notable improvement in outcomes (Table 4).

Table 3.Mean PROM scores by Herniation Location
PROM HNP I Mean ± SD *p-value HNP II Mean ± SD *p-value †p-value
VAS Back
Preoperative 5.7 ± 2.9 (68) - 6.2 ± 2.8 (43) - 0.388
6-weeks 2.4 ± 2.7 (57) <0.001 3.4 ± 2.6 (32) <0.001 0.108
12-weeks 2.4 ± 2.8 (29) <0.001 3.5 ± 2.9 (22) <0.001 0.184
6-months 2.5 ± 2.3 (22) <0.001 3.8 ± 3.4 (17) <0.001 0.232
1-year 2.9 ± 3.3 (18) 0.054 4.2 ± 2.5 (9) 0.104 0.166
2-years 4.3 ± 3.1 (7) 0.104 6.0 ± 2.9 (5) 0.087 0.462
VAS Leg
Preoperative 5.7 ± 3.1 (57) - 6.9 ± 2.6 (32) - 0.053
6-weeks 2.5 ± 2.8 (46) <0.001 3.2 ± 2.6 (21) <0.001 0.277
12-weeks 1.9 ± 2.6 (25) <0.001 3.7 ± 2.7 (15) <0.001 0.040
6-months 1.7 ± 2.1 (18) 0.001 4.2 ± 2.8 (11) 0.007 0.009
1-year 1.7 ± 2.4 (17) 0.019 1.9 ± 2.3 (9) <0.001 0.915
2-years 3.5 ± 2.8 (7) 0.048 5.1 ± 2.1 (5) 0.003 0.201
ODI
Preoperative 45.2 ± 21.9 (58) - 41.6 ± 18.9 (32) - 0.437
6-weeks 21.4 ± 17.9 (51) <0.001 28.1 ± 17.6 (25) <0.001 0.131
12-weeks 17.6 ± 20.3 (29) <0.001 32.3 ± 18.0 (17) 0.031 0.005
6-months 18.9 ± 23.7 (21) <0.001 36.1 ± 21.6 (12) 0.027 0.019
1-year 20.0 ± 20.4 (21) <0.001 28.6 ± 16.8 (12) 0.123 0.164
2-years 31.6 ± 16.3 (7) 0.011 39.6 ± 12.1 (5) 0.215 0.582
SF-12 PCS
Preoperative 31.0 ± 9.0 (52) - 29.4 ± 8.6 (25) - 0.476
6-weeks 40.1 ± 10.4 (40) <0.001 35.8 ± 8.9 (23) 0.005 0.109
12-weeks 45.9 ± 10.6 (22) <0.001 36.4 ± 8.9 (11) 0.028 0.015
6-months 44.7 ± 12.9 (20) 0.002 39.6 ± 11.8 (13) 0.058 0.185
1-year 46.3 ± 12.1 (19) <0.001 37.8 ± 12.5 (11) 0.206 0.093
2-years 44.5 ± 8.9 (13) <0.001 42.3 ± 11.1 (7) 0.247 0.663
PROMIS PF
Preoperative 34.9 ± 7.2 (34) - 37.5 ± 6.5 (18) - 0.197
6-weeks 45.2 ± 11.6 (31) <0.001 42.8 ± 5.4 (12) 0.008 0.487
12-weeks 48.9 ± 12.4 (18) 0.001 40.1 ± 6.5 (8) 0.009 0.068
6-months 47.9 ± 10.8 (15) 0.002 42.4 ± 8.9 (8) 0.242 0.272
1-year 50.7 ± 12.5 (17) <0.001 39.4 ± 8.5 (5) 0.894 0.037
2-years 46.5 ± 7.1 (7) 0.013 43.5 ± 6.6 (5) 0.329 0.474
PHQ-9
Preoperative 6.3 ± 5.9 (37) - 4.4 ± 5.1 (21) - 0.225
6-weeks 2.6 ± 3.6 (29) <0.001 2.7 ± 2.5 (15) 0.094 0.905
12-weeks 1.8 ± 3.6 (19) <0.001 2.7 ± 1.6 (7) 0.322 0.063
6-months 1.9 ± 3.8 (14) 0.001 3.1 ± 6.0 (12) 0.026 0.535
1-year 2.5 ± 3.3 (14) 0.031 8.4 ± 7.8 (5) 0.968 0.028
2-years 2.5 ± 2.9 (7) 0.047 4.7 ± 5.6 (4) 0.885 0.563

* p-values calculated using paired t-test to evaluate improvement from preoperative timepoint
† p-values calculated using linear regression to evaluate impact of location on mean values
Boldface indicates statistical significance

Table 4.MCID Achievement by Herniation Location
PROM HNP I Mean ± SD HNP II Mean ± SD †p-value
VAS Back (2.2) (Parker et al. 2012)
6-weeks 64.9% (37) 59.4% (19) 0.604
12-weeks 51.7% (15) 63.6% (14) 0.396
6-months 59.1% (13) 62.5% (10) 0.832
1-year 44.4% (8) 62.5% (5) 0.399
2-year 40.0% (2) 20.0% (1) 0.497
Overall 75.4% (43) 75.8% (25) 0.973
VAS Leg (5.0) (Parker et al. 2012)
6-weeks 39.1% (18) 38.1% (8) 0.936
12-weeks 48.0% (12) 33.3% (5) 0.366
6-months 50.0% (9) 20.0% (2) 0.132
1-year 35.3% (6) 75.0% (3) 0.076
2-year 20.0% (1) 0.0% (0) 0.999
Overall 52.1% (25) 45.5% (10) 0.607
ODI (8.2) (Parker et al. 2012)
6-weeks 65.9% (31) 65.0% (13) 0.940
12-weeks 76.9% (20) 46.7% (7) 0.055
6-months 78.9% (15) 70.0% (7) 0.594
1-year 77.8% (14) 62.5% (5) 0.422
2-year 80.0% (4) 20.0% (1) 0.080
Overall 84.3% (43) 83.3% (20) 0.914
SF-12 PCS (2.5) (Parker et al. 2012)
6-weeks 70.6% (24) 52.9% (9) 0.218
12-weeks 84.2% (16) 70.0% (7) 0.376
6-months 66.7% (12) 72.7% (8) 0.732
1-year 86.7% (13) 50.0% (4) 0.060
2-year 88.9% (8) 60.0% (3) 0.214
Overall 85.4% (35) 75.0% (15) 0.332
PROMIS PF (3.0) (Hung et al. 2018)
6-weeks 32.4% (11) 31.3% (5) 0.938
12-weeks 31.6% (6) 50.0% (5) 0.333
6-months 27.8% (5) 36.4% (4) 0.629
1-year 26.7% (4) 25.0% (2) 0.931
2-year 22.2% (2) 20.0% (1) 0.922
Overall 31.7% (13) 47.4% (9) 0.245
PHQ-9 (3.0) (Parker et al. 2012)
6-weeks 84.6% (22) 70.0% (7) 0.336
12-weeks 73.3% (11) 83.3% (5) 0.630
6-months 81.8% (9) 50.0% (3) 0.174
1-year 84.6% (11) 25.0% (1) 0.043
2-year 100.0% (5) 66.7% (2) 0.999
Overall 90.3% (28) 83.3% (10) 0.534

† p-values calculated using logistic regression to evaluate impact of location on rates of MCID achievement
Boldface indicates statistical significance

Statistical Analysis

Stata 16.0 (StataCorp LP, College Station, TX) was used for data analysis. Both the demographic (Table 1) and perioperative characteristics data (Table 2) had mean and standard deviation values calculated, and significance was calculated with Chi square analysis or paired sample t-test, for categorical and continuous variables, respectively. At each temporal interval of follow-up within cohorts, mean and standard deviation values were calculated for all PROMs (Table 3. In addition, all PROMs were assessed for MCID at each follow-up time (Table 4). Variations in rates of MCID achievement between groups were assessed using a simple logistic regression. The following prior established thresholds were used for MCID values: VAS back (2.2) (Parker et al. 2012), VAS leg (5.0) (Parker et al. 2012), ODI (8.2) (Parker et al. 2012), SF-12 PCS (2.5) (Parker et al. 2012), PROMIS-PF (3.0) (Hung et al. 2018), PHQ-9 (3.0) (Parker et al. 2012).

Results

Descriptive Analysis

A total of 122 patients were included in the study cohort, 74 of whom were classified in the HNP I cohort, and 48 in the HNP II cohort. The HNP I cohort had a mean age of 40.8 years with most patients (74.3%) being male and recorded a mean BMI of 28.9 kg/m2 (Table 1). The HNP II cohort had a mean age of 49.2 years, with the majority (68.7%) of male gender, and having a mean BMI of 30.1 kg/m2 (Table 1). Differences were demonstrated between cohorts for mean age (p<0.001), insurance status (p=0.040), and hypertension status (p=0.010) (Table 1). A significantly greater proportion of patients in the HNP II cohort had a longer preoperative course of symptoms (253.9 days versus the 166.7 days in the HNP I cohort, p=0.046). Other perioperative characteristics for operative duration, estimated intraoperative blood loss, length of stay, and postoperative complications yielded non significantly different results among the cohorts (Table 2). The HNP I cohort demonstrated a mean operative time of 48.5 minutes, mean EBL of 28.5 mL, and length of stay of 6.4 days. Comparatively, the HNP II cohort had a mean operative time of 43.7 minutes, mean EBL of 28.4 mL, and length of stay of 9.4 days (Table 2). The majority of participants underwent surgery at the L4-L5 level (45.1%). Only one patient included in this study experienced postoperative complications, consisting of urinary retention requiring hospital admission and observation.

Primary Outcome Measures

Both cohorts noted significant improvement in VAS Leg through the entire 2-year follow-up intervals (p≤0.048, all). The HNP I cohort also notably reported significantly improved PROM scores at all follow-up periods for ODI, SF-12 PCS, PROMIS PF, and PHQ-9, while noting improvement in VAS Back at 6-weeks, 12-weeks, and 6-months (p≤0.048, all). Comparatively, the HNP II cohort demonstrated variable improvement in PROMs at 12-weeks for SF-12 PCS and PROMIS PF (p≤0.028, all), through 6-months for ODI (p≤0.031, all), and only at the 6-month follow-up for PHQ-9 (p=0.026). The following differences in mean PROMs between cohorts were demonstrated: VAS Leg at 12-weeks (p=0.40) and 6-months (p=0.009), ODI at 12-weeks (p=0.005) and 6-months (p=0.019), SF-12 PCS at 12-weeks (p=0.015), PROMIS-PF at 1-year (p=0.037), and PHQ-9 at 1-year (p=0.028) (Table 3). Rates of MCID achievement were similar between cohorts at all follow-up intervals across the PROMs (Table 4). Patients in the HNP I were most likely to achieve overall MCID in PHQ-9 (90.3%), followed by SF-12 PCS (85.4%), ODI (84.3%), VAS Back (75.4%), VAS Leg (52.1%), and PROMIS-PF (31.7%). The HNP II cohort demonstrated the highest rates of MCID achievement in PHQ-9 and ODI (83.3%), followed by VAS Back (75.8%), SF-12 PCS (75.0%), PROMIS-PF (47.4%), and VAS Leg (45.5%) (Table 4). These results display that location and size of lumbar disc herniation may yield a significant effect on postoperative PROMs at intermittent time points, while conversely not impacting rates of MCID achievement for the same outcomes.

Discussion

Patient reported outcome measures (PROMs) provide insight into individualized experiences of pain and disability in the preoperative and postoperative setting. In addition to being able to quantify individual patient experiences, PROMs can be used to observe an individual patient’s unique experience with surgical intervention (Jacob et al. 2021; Ogura et al. 2020). This can be of utility in determining efficacy of surgical intervention and postoperative satisfaction in certain subsets of patients. The modality of surgical intervention in which we were interested in studying was minimally invasive lumbar decompression (MIS LD), often utilized to treat lumbar disc herniations (LDH) (Sunderland et al. 2021). Locations of LDHs include central/paracentral, with differing locations of herniation having an associated clinical symptom profile. LDH location may additionally have an impact on postoperative clinical outcomes as well as postoperative clinical improvement. Therefore, we aimed to observe the impact of central/paracentral herniations (HNP I) versus extraforaminal/far lateral herniations (HNP II) on postoperative PROMS. Given the frequency of LD surgery for the treatment of LDH and the variable demographic affected by the pathology, there has been increasing interest in factors that may influence postoperative PROMs in this population. Furthermore, there are few studies that have examined the impact of location and size of LDH on PROMs.

Clinical Outcomes

Our findings show that there were significant improvements in the VAS back scores in both groups up to the 6 month mark and in the VAS leg scores up to the 2 year mark. In both sets of VAS scores, the HNP II cohort had higher reported levels of pain throughout the recovery process. This suggests that the extraforaminal/far lateral herniations may have been causing patients more pain in the postoperative setting than the central/paracentral herniations. This is consistent with findings observed by a study by Lee et al. in 2016 that showed evidence that foraminal/extraforaminal disc herniation was more closely related to radiating pain than central/subarticular herniation (Lee and Lee 2016). Pain associated with the foraminal/extraforaminal herniations was due to mechanical irritation or compression of the nerve roots in a more direct fashion than central/subarticular herniation (Lee and Lee 2016). Based on those findings, the observed VAS scores can be attributed to the higher propensity of foraminal/extraforaminal herniations to cause issues with peripheral nerves. From these observations in the HNP II cohort, we may glean insight into patterns seen in the rest of the PROMs. The increase in reported pain in HNP II may have been contributing to worsened recovery reported in the PROMs discussed below.

Upon review of the resulted trends in ODI, the HNP I cohort saw significant improvements in their ODI score up to the 2 year mark. The HNP II cohort showed significant improvements only up to the 6 month mark. These findings indicate less perceived recovery of disability in patients with foraminal/extraforaminal herniations compared to central/paracentral herniations. Our findings align with the retrospective cohort study by Khan et al. in 2019, which showed that far lateral lumbar disc herniations were associated with worsened ODI scores postoperatively compared to central/paracentral herniations (Khan et al. 2019). This noted difference was attributed to the anatomy of the discs, whereby lateral herniations would be more likely to compress the dorsal root ganglion compared to central ones (Khan et al. 2019). The findings are also consistent with our observations in VAS scores. The increase in pain associated with foraminal/extraforaminal herniation could cause these patients to subsequently feel more disabled in the postoperative period. However, both HNP I and HNP II cohorts eventually do show improvement from pre-operative baseline ODI (albeit moreso with HNP I). These trends are supported elsewhere in the literature as well. In one study by Kulkarni et al. that analyzed ODI trends for a mean of 22 months after micro endoscopic lumbar discectomy, mean ODI scores went from 59.5 to 22.6 (Kulkarni, Bassi, and Dhruv 2014). Therefore, our findings are consistent with known trends in ODI scores. Based on these trends, overall perception of disability is eventually expected to improve regardless of location of herniation.

In terms of physical function, our results demonstrated higher mean SF-12 PCS and PROMIS PF scores at all postoperative stages in the HNP I cohort. These findings strengthen our earlier observations that central/paracentral herniations are associated with decreased back and leg pain, decreased disability, and improved physical and mental function per SF-12 PCS and PROMIS PF. Of note, these two PROMs also were shown to improve more in the HNP I cohort. A study by Patel et al. in 2019 corroborates these observations. In this study, patients with worsened disability as rated on the PROMIS PF were shown to experience increased pain and have less improvement in ODI, SF-12 PCS, and VAS back/leg pain after MIS TLIF (Patel, Bawa, Haws, et al. 2019). Our findings match those observed by that study. Based on these similarities, it seems as if worsened pain and increased perceived disability were detriments to the overall recovery of patients after MIS LD. Upon review of our findings thus far, differences between the HNP I and HNP II cohort may have been caused by anatomic differences in location of herniation (Khan et al. 2019). These anatomic differences tend to cause more pain, which lowers a patient’s ability to function and recover.

The trends in PHQ-9 data between both cohorts mirror trends observed in other PROMs. The HNP I cohort showed statistically significant improvements in PHQ-9 scores up to the 2 year mark. On the other hand, the HNP II cohort only showed significant improvement at the 6 month mark. In a retrospective cohort study in 2019 by Patel et al., preoperative depressive symptoms via PHQ-9 scores before minimally invasive transforaminal lumbar fusions were observed to be associated with less improvement in ODI and VAS scores (Patel et al. 2019). While there is little significant PHQ-9 data in the HNP II cohort, we can make some observations based on the earlier data we have gathered. The worsened VAS scores and decreased perceived functional status in the HNP II cohort may have relation to the worse improvement in PHQ-9 scores. In a literature review by Ghoneim et al., the data reviewed showed depression in patients undergoing surgery may be associated with greater postoperative pain and poor quality of life as related to health (Ghoneim and O’Hara 2016). From this data, it is likely that pain, depression, functional status, and disability all play a role in individual patient experiences in the postoperative setting. This suggests that there may be a multifactorial interplay that is contributing to the differences seen in the postoperative course between the HNP I and HNP II cohort.

In all PROMs, the HNP I cohort generally experienced more favorable results throughout their recovery. Despite the speculations that can be made throughout different time periods in the postoperative setting, the properties of the LDHs did not impact rates of MCID achievement for any PROMs. This suggests that patients with differing LDH characteristics can have different degrees of improvement in their recovery, but ultimately, they will arrive at a similar degrees of resolution. As location of disc herniation clearly differentially impacts patient postoperative improvement rates for disability, pain, physical function, and mental health surgeons can utilize results of this study to help set patient expectation preoperatively and manage patient expectations postoperatively in patients undergoing MIS LD based on location of their disc herniation.

Limitations

There are several limitations to consider when reviewing this study. First, all of the data was compiled from one spine surgeon’s practice at his single academic institution. Due to all of the studied patients being selected from this one practice, generalizability to the broad population may be restricted. Statistically significant differences were noted between cohorts, specifically in mean age, insurance type, and hypertension status. A mean age of 8.4 years older in the HNP II cohort could have confounding effects on postoperative recovery and disability status. Differences in insurance types may point to social determinants of health altering postoperative outcomes and additionally may serve as source of selection bias. A 19.1% difference in the number of patients with hypertension between cohorts also complicates interpretation of recovery in the setting of overall cardiovascular health. As these three variables are potential confounders to our study’s results and a notable limitation, they potentially complicate interpretation of study results. However, it was our determination that the decrease in power resulting from propensity score matching cohorts outweighed the benefit of matching. Finally, the mean duration of symptoms in the HNP II cohort was 87.2 days longer than in the HNP I cohort. Experiencing adverse symptoms for a longer period of time can confound a patient’s perception of pain, functional status, disability, and mood.

Conclusion

Patients demonstrated significant differences in leg pain, disability, physical function, and mental health based on the properties of the herniation. However, this effect was not observed with achievement of MCID. This suggests that depending on the size and location of a herniation, patients may experience varying degrees of improvement throughout their course of postoperative recovery but will ultimately arrive at a similar resolution of symptoms.

Submitted: January 01, 2022 EDT

Accepted: February 04, 2022 EDT

References

Ahn, Junyoung, Aamir Iqbal, Blaine T. Manning, Spencer Leblang, Daniel D. Bohl, Benjamin C. Mayo, Dustin H. Massel, and Kern Singh. 2016. “Minimally Invasive Lumbar Decompression—the Surgical Learning Curve.” The Spine Journal 16 (8): 909–16. https:/​/​doi.org/​10.1016/​j.spinee.2015.07.455.
Google Scholar
Allen, R. Todd, Jeffrey A. Rihn, Steven D. Glassman, Bradford Currier, Todd J. Albert, and Frank M. Phillips. 2009. “An Evidence-Based Approach to Spine Surgery.” American Journal of Medical Quality 24 (6_suppl): 15S-24S. https:/​/​doi.org/​10.1177/​1062860609348743.
Google Scholar
Amin, Raj M., Nicholas S. Andrade, and Brian J. Neuman. 2017. “Lumbar Disc Herniation.” Current Reviews in Musculoskeletal Medicine 10 (4): 507–16. https:/​/​doi.org/​10.1007/​s12178-017-9441-4.
Google ScholarPubMed CentralPubMed
Finkelstein, Joel A., and Carolyn E. Schwartz. 2019. “Patient-Reported Outcomes in Spine Surgery: Past, Current, and Future Directions.” Journal of Neurosurgery: Spine 31 (2): 155–64. https:/​/​doi.org/​10.3171/​2019.1.spine18770.
Google Scholar
Ghoneim, Mohamed M., and Michael W. O’Hara. 2016. “Depression and Postoperative Complications: An Overview.” BMC Surgery 16 (1). https:/​/​doi.org/​10.1186/​s12893-016-0120-y.
Google ScholarPubMed CentralPubMed
Goh, Graham S., Ming Han Lincoln Liow, Wai-Mun Yue, Seang-Beng Tan, and John Li-Tat Chen. 2021. “Are Patient-Reported Outcomes of Minimally Invasive Transforaminal Lumbar Interbody Fusion Influenced by Preoperative Mental Health?” Global Spine Journal 11 (4): 500–508. https:/​/​doi.org/​10.1177/​2192568220912712.
Google ScholarPubMed CentralPubMed
Gupta, Anmol, Shivam Upadhyaya, Caleb M. Yeung, Peter J. Ostergaard, Harold A. Fogel, Thomas Cha, Joseph Schwab, Chris Bono, and Stuart Hershman. 2020. “Does Size Matter? An Analysis of the Effect of Lumbar Disc Herniation Size on the Success of Nonoperative Treatment.” Global Spine Journal 10 (7): 881–87. https:/​/​doi.org/​10.1177/​2192568219880822.
Google ScholarPubMed CentralPubMed
Hung, Man, Charles L. Saltzman, Richard Kendall, Jerry Bounsanga, Maren W. Voss, Brandon Lawrence, Ryan Spiker, and Darrel Brodke. 2018. “What Are the MCIDs for PROMIS, NDI, and ODI Instruments Among Patients With Spinal Conditions?” Clinical Orthopaedics & Related Research 476 (10): 2027–36. https:/​/​doi.org/​10.1097/​corr.0000000000000419.
Google ScholarPubMed CentralPubMed
Jacob, Kevin C., Madhav R. Patel, Alexander W. Parsons, Nisheka N. Vanjani, Hanna Pawlowski, Michael C. Prabhu, and Kern Singh. 2021. “The Effect of the Severity of Preoperative Back Pain on Patient-Reported Outcomes, Recovery Ratios, and Patient Satisfaction Following Minimally Invasive Transforaminal Lumbar Interbody Fusion (MIS-TLIF).” World Neurosurgery 156:e254–65. https:/​/​doi.org/​10.1016/​j.wneu.2021.09.053.
Google Scholar
Jenkins, Nathaniel W., James M. Parrish, Nadia M. Hrynewycz, Thomas S. Brundage, and Kern Singh. 2020. “Longitudinal Evaluation of Patient-Reported Outcomes Measurement Information System for Back and Leg Pain in Minimally Invasive Transforaminal Lumbar Interbody Fusion.” Neurospine 17 (4): 862–70. https:/​/​doi.org/​10.14245/​ns.1938398.199.
Google ScholarPubMed CentralPubMed
Khan, Jannat M., Dennis McKinney, Bryce A. Basques, Philip K. Louie, Deven Carroll, Justin Paul, Arya Varthi, Sravisht Iyer, and Howard S. An. 2019. “Clinical Presentation and Outcomes of Patients With a Lumbar Far Lateral Herniated Nucleus Pulposus as Compared to Those With a Central or Paracentral Herniation.” Global Spine Journal 9 (5): 480–86. https:/​/​doi.org/​10.1177/​2192568218800055.
Google ScholarPubMed CentralPubMed
Khanna, Ryan, Hani Malone, Kavantissa M. Keppetipola, Harel Deutsch, Richard G. Fessler, Ricardo B. Fontes, and John E. O’Toole. 2021. “Multilevel Minimally Invasive Lumbar Decompression: Clinical Efficacy and Durability to 2 Years.” International Journal of Spine Surgery 15 (4): 795–802. https:/​/​doi.org/​10.14444/​8102.
Google ScholarPubMed CentralPubMed
Kim, Chi Heon, Yunhee Choi, Chun Kee Chung, Ki-Jeong Kim, Dong Ah Shin, Youn-Kwan Park, Woo-Keun Kwon, et al. 2021. “Nonsurgical Treatment Outcomes for Surgical Candidates with Lumbar Disc Herniation: A Comprehensive Cohort Study.” Scientific Reports 11 (1): 1–12. https:/​/​doi.org/​10.1038/​s41598-021-83471-y.
Google ScholarPubMed CentralPubMed
Kulkarni, Arvind G., Anupreet Bassi, and Abhilash Dhruv. 2014. “Microendoscopic Lumbar Discectomy: Technique and Results of 188 Cases.” Indian Journal of Orthopaedics 48 (1): 81–87. https:/​/​doi.org/​10.4103/​0019-5413.125511.
Google ScholarPubMed CentralPubMed
Lee, Jung Hwan, and Sang-Ho Lee. 2016. “Clinical and Radiological Characteristics of Lumbosacral Lateral Disc Herniation in Comparison With Those of Medial Disc Herniation.” Medicine 95 (7): e2733. https:/​/​doi.org/​10.1097/​md.0000000000002733.
Google ScholarPubMed CentralPubMed
McCormick, J. D., B. C. Werner, and A. L. Shimer. 2013. “Patient-Reported Outcome Measures in Spine Surgery.” Journal of the American Academy of Orthopaedic Surgeons 21 (2): 99–107. https:/​/​doi.org/​10.5435/​jaaos-21-02-99.
Google Scholar
Narain, Ankur S., Fady Y. Hijji, Jonathan S. Markowitz, Krishna T. Kudaravalli, Kelly H. Yom, and Kern Singh. 2017. “Minimally Invasive Techniques for Lumbar Decompressions and Fusions.” Current Reviews in Musculoskeletal Medicine 10 (4): 559–66. https:/​/​doi.org/​10.1007/​s12178-017-9446-z.
Google ScholarPubMed CentralPubMed
Nolte, Michael T., Nathaniel W. Jenkins, James M. Parrish, Shruthi Mohan, Cara E. Geoghegan, Caroline N. Jadczak, Nadia M. Hrynewycz, and Kern Singh. 2021. “The Influence of Sex on Clinical Outcomes in Minimally Invasive Lumbar Decompression.” International Journal of Spine Surgery 15 (4): 763–69. https:/​/​doi.org/​10.14444/​8098.
Google ScholarPubMed CentralPubMed
Ogura, Yoji, Yoshiomi Kobayashi, Takahiro Kitagawa, Yoshiro Yonezawa, Yoshiyuki Takahashi, Kodai Yoshida, Akimasa Yasuda, Yoshio Shinozaki, and Jun Ogawa. 2020. “Outcome Measures Reflecting Patient Satisfaction Following Decompression Surgery for Lumbar Spinal Stenosis: Comparison of Major Outcome Measures.” Clinical Neurology and Neurosurgery 191 (April):105710. https:/​/​doi.org/​10.1016/​j.clineuro.2020.105710.
Google Scholar
Parker, Scott L., Stephen K. Mendenhall, David N. Shau, Owoicho Adogwa, William N. Anderson, Clinton J. Devin, and Matthew J. McGirt. 2012. “Minimum Clinically Important Difference in Pain, Disability, and Quality of Life after Neural Decompression and Fusion for Same-Level Recurrent Lumbar Stenosis: Understanding Clinical versus Statistical Significance.” Journal of Neurosurgery: Spine 16 (5): 471–78. https:/​/​doi.org/​10.3171/​2012.1.spine11842.
Google Scholar
Patel, Dil V., M.S. Bawa, B.E. Haws, et al. 2019. “PROMIS Physical Function for Prediction of Postoperative Pain, Narcotics Consumption, and Patient-Reported Outcomes Following Minimally Invasive Transforaminal Lumbar Interbody Fusion.” J Neurosurg Spine, February, 1–7.
Google Scholar
Patel, Dil V., Joon S. Yoo, Benjamin Khechen, Brittany E. Haws, Andrew M. Block, Eric H. Lamoutte, Sailee S. Karmarkar, and Kern Singh. 2019. “PHQ-9 Score Predicts Postoperative Outcomes Following Minimally Invasive Transforaminal Lumbar Interbody Fusion.” Clinical Spine Surgery: A Spine Publication 32 (10): 444–48. https:/​/​doi.org/​10.1097/​bsd.0000000000000818.
Google Scholar
Sunderland, Geraint, Mitchell Foster, Sujay Dheerendra, and Robin Pillay. 2021. “Patient-Reported Outcomes Following Lumbar Decompression Surgery: A Review of 2699 Cases.” Global Spine Journal 11 (2): 172–79. https:/​/​doi.org/​10.1177/​2192568219896541.
Google ScholarPubMed CentralPubMed
Weinstein, James N., Jon D. Lurie, Tor D. Tosteson, Jonathan S. Skinner, Brett Hanscom, Anna N. A. Tosteson, Harry Herkowitz, et al. 2006. “Surgical vs Nonoperative Treatment for Lumbar Disk Herniation: The Spine Patient Outcomes Research Trial (SPORT) Observational Cohort.” JAMA 296 (20): 2451. https:/​/​doi.org/​10.1001/​jama.296.20.2451.
Google ScholarPubMed CentralPubMed
Weinstein, James N., Tor D. Tosteson, Jon D. Lurie, Anna N.A. Tosteson, Emily Blood, Brett Hanscom, Harry Herkowitz, et al. 2008. “Surgical versus Nonsurgical Therapy for Lumbar Spinal Stenosis.” New England Journal of Medicine 358 (8): 794–810. https:/​/​doi.org/​10.1056/​nejmoa0707136.
Google ScholarPubMed CentralPubMed

This website uses cookies

We use cookies to enhance your experience and support COUNTER Metrics for transparent reporting of readership statistics. Cookie data is not sold to third parties or used for marketing purposes.

Powered by Scholastica, the modern academic journal management system